Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994-2003
- PMID: 17200832
- DOI: 10.1007/s00228-006-0239-3
Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994-2003
Abstract
Objectives: The prescription pattern of statins in the Local Health Unit (LHU) of Treviso (northern Italy) over a 10-year period was evaluated, with the aim of evaluating the persistence with and adherence to therapy.
Methods: Data on 21,393 subjects who received at least one prescription for statins during the period between January 1, 1994 and December 31, 2003 were retrieved from the LHU database in order to track the pharmacological history of individual patients. The data included age, sex, drug formulation, strength, number of drug packages prescribed, and prescription date. The adopted indicators for drug utilization included the Defined Daily Dose (DDD), the Received Daily Dose (RDD), and a surrogated Prescribed Daily Dose (sPDD), extrapolated from available prescription data. An Adherence to Therapy Index (ATI) was calculated from the ratio between the amount of drug actually prescribed and the amount of sPDD. Based on the ATI, patients were grouped into non-adherent, poor-adherent, and good-adherent groups. The distribution of adherence level among patient-age classes and statin-prescribed patients in primary or secondary prevention was evaluated.
Results: All drug-utilization indicators showed an increase in statin use over the study period in terms of both the number of prescribed patients and the sPDD. Persistence with and adherence to therapy remained low, with a 50% discontinuation rate in the first year, and persistent patients did not follow the therapy regularly. Patients in secondary prevention were the most adherent to their drug regimen, although only 41% of these had a good compliance.
Conclusions: Our findings suggest an increase in statin use which is, however, accompanied by poor patient persistence with and adherence to statin therapy.
Similar articles
-
Initial treatment of hypertension and adherence to therapy in general practice in Italy.Eur J Clin Pharmacol. 2005 Sep;61(8):603-9. doi: 10.1007/s00228-005-0957-y. Epub 2005 Aug 5. Eur J Clin Pharmacol. 2005. PMID: 16082539
-
Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012-2018).BMC Cardiovasc Disord. 2020 Apr 25;20(1):201. doi: 10.1186/s12872-020-01482-5. BMC Cardiovasc Disord. 2020. PMID: 32334525 Free PMC article.
-
Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study.BMC Clin Pharmacol. 2007 Dec 5;7:14. doi: 10.1186/1472-6904-7-14. BMC Clin Pharmacol. 2007. PMID: 18053228 Free PMC article.
-
Adherence and Persistence Among Statin Users Aged 65 Years and Over: A Systematic Review and Meta-analysis.J Gerontol A Biol Sci Med Sci. 2018 May 9;73(6):813-819. doi: 10.1093/gerona/glx169. J Gerontol A Biol Sci Med Sci. 2018. PMID: 28958039
-
Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual-level drug dispensing data.Pharmacoepidemiol Drug Saf. 2022 Oct;31(10):1015-1026. doi: 10.1002/pds.5490. Epub 2022 Aug 11. Pharmacoepidemiol Drug Saf. 2022. PMID: 35819240 Free PMC article. Review.
Cited by
-
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study.BMC Cardiovasc Disord. 2011 Jul 26;11:46. doi: 10.1186/1471-2261-11-46. BMC Cardiovasc Disord. 2011. PMID: 21791073 Free PMC article.
-
Gender differences in statin prescription rates, adequacy of dosing, and association of statin therapy with outcome after heart failure hospitalization: a retrospective analysis in a community setting.Eur J Clin Pharmacol. 2016 Mar;72(3):311-9. doi: 10.1007/s00228-015-1980-2. Epub 2015 Nov 19. Eur J Clin Pharmacol. 2016. PMID: 26581760
-
Long-Lasting Control of LDL Cholesterol Induces a 40% Reduction in the Incidence of Cardiovascular Events: New Insights from a 7-Year Study.J Pharmacol Exp Ther. 2024 Feb 15;388(3):742-747. doi: 10.1124/jpet.123.001878. J Pharmacol Exp Ther. 2024. PMID: 37775305 Free PMC article.
-
Sense of Coherence is associated with LDL-cholesterol in patients with type 1 diabetes - The PROLONG-Steno study.J Clin Transl Endocrinol. 2017 Feb 11;8:1-5. doi: 10.1016/j.jcte.2017.01.003. eCollection 2017 Jun. J Clin Transl Endocrinol. 2017. PMID: 29067252 Free PMC article.
-
Medication adherence: WHO cares?Mayo Clin Proc. 2011 Apr;86(4):304-14. doi: 10.4065/mcp.2010.0575. Epub 2011 Mar 9. Mayo Clin Proc. 2011. PMID: 21389250 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials